Investigation Report on China’s Esomeprazole Market 2021-2025

$2,600$3,900

According to CRI analysis, the sales of Esomeprazole have grown steadily from 2016 to 2019. In 2020, its sales fell by about 6% to CNY1.561 billion in 2020.

Clear

Description

Description
Esomeprazole is a proton pump inhibitor (PPI), which can effectively inhibit gastric acid secretion. It is clinically used to treat gastric acid-related diseases such as gastroesophageal reflux disease (GERD) and erosive reflux esophagitis (ERD). Its product, NEXIUM was developed by AstraZeneca AB. Esomeprazole was approved in China in 2007. By 2020, in addition to AstraZeneca AB, there are more than 10 generic drug manufacturers in the Chinese Esomeprazole market, such as Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd. and Chongqing Lummy Pharmaceutical Co., Ltd.

According to CRI analysis, the sales of Esomeprazole have grown steadily from 2016 to 2019. In 2020, its sales fell by about 6% to CNY1.561 billion in 2020. The main reason is that the Covid-19 epidemic has affected the hospital’s overall diagnosis and treatment business, resulting in a decline in its sales. The CAGR of Esomeprazole sales in the Chinese market from 2016 to 2020 is 12%.

CRI predicts that the sales volume of Esomeprazole in the Chinese market will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. In addition, as of the first half of 2021, there are 13 pharmaceutical companies that have applied to enter the Esomeprazole market in China. It can be expected that the price of Esomeprazole will decrease with the addition of new manufacturers, and both sales and sales volume will grow. Moreover, compared with similar drugs, Esomeprazole has the advantages of short-course therapy, stable curative effect, fast and long-lasting effect, so the sales volume of Esomeprazole in China will maintain a growth trend.

Topics Covered:
-The impact of COVID-19 on China’s Esomeprazole market
– Sales value of China’s Esomeprazole 2016-2020
– Competitive landscape of China’s Esomeprazole market
– Prices of Esomeprazole in China
– Prices of Esomeprazole in China by regions and manufacturers
– Analysis of factors affecting the development of China’s Esomeprazole market
– Prospect of China’s Esomeprazole market from 2021 to 2025

Additional information

Publisher

Date Published

Pages

Charts

Format

Table of Contents

Table of Contents
1 Relevant Concept of Esomeprazole
1.1 Indications for Esomeprazole
1.2 Development of Esomeprazole in China
1.3 Governmental Approval of Esomeprazole in China
1.4 The Impact of COVID-19 on Esomeprazole sales in China

2 Sales of Esomeprazole in China, 2016-2020
2.1 Sales Value of Esomeprazole
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Esomeprazole
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Esomeprazole by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.3 Enteric Tablets
2.3.3 Enteric Capsules

3 Analysis of Major Esomeprazole Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Esomeprazole Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 AstraZeneca AB
3.2.1 Enterprise Profile
3.2.2 Sales of NEXIUM (AstraZeneca AB’s Esomeprazole) in China
3.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Aisuping (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.’s Esomeprazole) in China
3.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Aoxikang (Jiangsu Aosaikang Pharmaceutical Co., Ltd.’s Esomeprazole) in China
3.5 Chongqing Lummy Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Laimeishu (Chongqing Lummy Pharmaceutical Co., Ltd.’s Esomeprazole ) in China
3.6 Liantian Pharmaceutical (Hubei) Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Xinlanxue (Liantian Pharmaceutical (Hubei) Co.,Ltd.’s Esomeprazole ) in China

4 Prices of Esomeprazole for Different Manufacturers in China, 2020-2021
4.1 AstraZeneca AB (NEXIUM)
4.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Aisuping)
4.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. (Aoxikang)
4.4 Chongqing Lummy Pharmaceutical Co., Ltd. (Laimeishu)
4.5 Liantian Pharmaceutical (Hubei) Co., Ltd.(Xinlanxue)

5 Prospect of Chinese Esomeprazole Market, 2021-2025
5.1 Influential Factors of Chinese Esomeprazole Market Development
5.1.1 The Impact of COVID-19 on Chinese Esomeprazole Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Esomeprazole Injection Registration in China
Chart Patent Information About Esomeprazole Enteric Tablets Registration in China
Chart Patent Information About Esomeprazole Enteric Capsules Registration in China
Chart Sales Value of Esomeprazole Injection over the World
Chart Sales Value of Esomeprazole Enteric Tablets over the World
Chart Sales Value of Esomeprazole Enteric Capsules over the World
Chart Sales Value of Esomeprazole Injection in China, 2016-2020
Chart Sales Value of Esomeprazole Enteric Tablets in China, 2016-2020
Chart Sales Value of Esomeprazole Enteric Capsules in China, 2016-2020
Chart Sales Value of Esomeprazole Injection in China by Regions, 2016-2020
Chart Sales Value of Esomeprazole Enteric Tablets in China by Regions, 2016-2020
Chart Sales Value of Esomeprazole Enteric Capsules in China by Regions, 2016-2020
Chart Sales Volume of Esomeprazole Injection in China, 2016-2020
Chart Sales Volume of Esomeprazole Enteric Tablets in China, 2016-2020
Chart Sales Volume of Esomeprazole Enteric Capsules in China, 2016-2020
Chart Sales Volume of Esomeprazole Injection in China by Regions, 2016-2020
Chart Sales Volume of Esomeprazole Enteric Tablets in China by Regions, 2016-2020
Chart Sales Volume of Esomeprazole Enteric Capsules in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Esomeprazole Injection Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Esomeprazole Enteric Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Esomeprazole Enteric Capsules Manufacturers in China, 2016-2020
Chart Sales Value and Volume of NEXIUM in China, 2016-2020
Chart Sales Value and Volume of Aisuping in China, 2016-2020
Chart Sales Value and Volume of Aoxikang in China, 2016-2020
Chart Sales Value and Volume of Laimeishu in China, 2016-2020
Chart Sales Value and Volume of Xinlanxue in China, 2016-2020
Chart Referential Prices of NEXIUM in China by Regions, 2020-2021
Chart Referential Prices of Aisuping in China by Regions, 2020-2021
Chart Referential Prices of Aoxikang in China by Regions, 2020-2021
Chart Referential Prices of Laimeishu in China by Regions, 2020-2021
Chart Referential Prices of Xinlanxue in China by Regions, 2020-2021
Chart Forecast on Sales Value of Esomeprazole Injection in China, 2021-2025
Chart Forecast on Sales Value of Esomeprazole Enteric Tablets in China, 2021-2025
Chart Forecast on Sales Value of Esomeprazole Enteric Capsules in China, 2021-2025
Chart Forecast on Sales Volume of Esomeprazole Injection in China, 2021-2025
Chart Forecast on Sales Volume of Esomeprazole Enteric Tablets in China, 2021-2025
Chart Forecast on Sales Volume of Esomeprazole Enteric Capsules in China, 2021-2025

RSS
Follow by Email